166 related articles for article (PubMed ID: 2429630)
1. [Primary cytostatic therapy of progressive squamous cell carcinoma of the oral cavity].
Bienengräber V
Arch Geschwulstforsch; 1986; 56(5):353-6. PubMed ID: 2429630
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx.
Tichler T; Ramon Y; Rath P; Hendler S; Brenner HJ
Isr J Med Sci; 1988; 24(9-10):539-44. PubMed ID: 2462551
[TBL] [Abstract][Full Text] [Related]
3. An effective combined therapy for advanced squamous cell carcinoma of the oral cavity: preoperative BVMM (bleomycin, vincristine, mitolactol plus methotrexate and leucovorin) chemotherapy followed by surgery.
Olasz L; Szabó I; Horváth A
Neoplasma; 1988; 35(5):591-7. PubMed ID: 3216933
[TBL] [Abstract][Full Text] [Related]
4. [Chemoinduction in inoperable oral carcinomas].
Bienengräber V
Stomatol DDR; 1986 Dec; 36(12):712-6. PubMed ID: 2438824
[No Abstract] [Full Text] [Related]
5. A comparative study of preoperative B-V-M-M chemotherapy and irradiation in advanced squamous cell cancer of the oral cavity.
Olasz L; Kwashie F; Herczegh P; Bruncsics Z; Horváth A; Királyfalvi L
Neoplasma; 1996; 43(1):51-6. PubMed ID: 8843961
[TBL] [Abstract][Full Text] [Related]
6. Stromal reaction of carcinomas after cytostatic therapy.
Pastrnák A; Jansa P; Podstata J; Brázda A
Acta Univ Palacki Olomuc Fac Med; 1987; 117():85-93. PubMed ID: 2470244
[No Abstract] [Full Text] [Related]
7. [Comparative study of 2 chemotherapy induction protocols. Cisplatinum-methotrexate-bleomycin and oncovin-methotrexate-bleomycin].
Laccourreye H; Beutter P; Brasnu D; Lacau-Saint-Guily J; Bassot V; Garabedian N; Jacquillat C
Ann Otolaryngol Chir Cervicofac; 1983; 100(4):269-74. PubMed ID: 6192747
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
[TBL] [Abstract][Full Text] [Related]
10. [Effect of local immunotherapy of interleukin 2(IL-2) in combination with chemotherapy upon intratumoral lymphocytes in oral squamous cell carcinomas].
Tang E; Hu Q; Zhou B
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):444-6. PubMed ID: 14732977
[TBL] [Abstract][Full Text] [Related]
11. [Results of an interdisciplinary study of primary inoperable stage T3 and T4 squamous cell carcinoma of the mouth, oropharynx and hypopharynx].
Rohrmeier M; Langnickel R; Hilpert P
HNO; 1987 Jan; 35(1):14-8. PubMed ID: 3558010
[TBL] [Abstract][Full Text] [Related]
12. [The remission of extensive cancers of the mouth and oropharynx with intra-arterial polychemotherapy with vincristine, methotrexate, bleomycin, cisplatin (VMBP)].
Mika H
Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):520-3. PubMed ID: 6183545
[TBL] [Abstract][Full Text] [Related]
13. [Clinical studies of preoperative tumor reductive chemotherapy with PPV regimen in the treatment of oral squamous cell carcinoma].
Jin Y; Shen Y; Ma G
Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 May; 30(3):166-8. PubMed ID: 7489653
[No Abstract] [Full Text] [Related]
14. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
[TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant radiochemotherapy for squamous cell carcinoma of the oral cavity].
Bootz F
HNO; 2008 Feb; 56(2):183-4. PubMed ID: 18231725
[No Abstract] [Full Text] [Related]
16. Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity: results from a single institution.
Okura M; Hiranuma T; Adachi T; Ogura T; Aikawa T; Yoshioka H; Hayashido Y; Kogo M; Matsuya T
Cancer; 1998 Mar; 82(5):804-15. PubMed ID: 9486567
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in the treatment of inoperable orofacial tumors with simultaneous radiotherapy and intra-arterial chemotherapy].
Szepesi T; Stadler B; Hohenberg G; Hollmann K; Kühböck J; Mailath G
Strahlentherapie; 1985 May; 161(5):299-307. PubMed ID: 2408359
[TBL] [Abstract][Full Text] [Related]
18. Combined regional chemotherapy and radiation therapy in the treatment of epidermoid carcinoma in the oro-facial region.
Danko J; Satko I; Durkovský J
Neoplasma; 1979; 26(3):345-50. PubMed ID: 93709
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
20. [A preliminary experience of chemotherapy using cisplatin (CDDP) in oral and maxillofacial carcinoma].
Qiu WL
Zhonghua Kou Qiang Yi Xue Za Zhi; 1989 Mar; 24(2):69-71, 127. PubMed ID: 2480209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
